期刊文献+

中药复方祛毒增宁胶囊抗艾滋病毒体外药效学的研究 被引量:4

In vitro pharmacodynamics study of an anti-HIV Chinese herbal formulation
原文传递
导出
摘要 本研究以现代医学为基础,结合中医辨症的原则,特别是经过体外抗病毒实验的筛选,选择既具有抗病毒作用,可增强机体免疫功能又符合中医辨症原则,以黄芩等4味中药组成复方,经过正交设计,优选提取溶剂和工艺,制成胶囊,暂定名为祛毒增宁胶囊(ZL-1)。体外药效学研究表明,祛毒增宁胶囊可有效抑制病毒在MT4、HeLa和PBMC中的复制,IC50分别为105.2、70.7及77.4μg·mL-1。祛毒增宁胶囊中主要成分JH与齐多夫定(AZT)不同剂量配伍,表现出明显的增效作用,同时,对蛋白酶抑制剂抗性株也有明显的抑制作用,在0.12mg·mL-1质量浓度下抑制率为100%。此制剂已完成临床前研究,并获批准进入临床观察阶段。 AIDS caused by HIV-1,is a major threat to human being.An anti-HIV formulation from Chinese herbs,so called "Qu Du Zeng Ning",have been recently developed.In this work,the pharmacodynamics of the formulation in vitro was studied.The results showed that Qu Du Zeng Ning inhibit the replication of HIV-1 efficiently in all cell-based assay,with IC 50 at 105.2,70.7,77.4 μg·mL-1,separately.A significant synergy between the formulation and zidovudine (AZT) was observed,and it also showed a potent activity against HIV-1 drug-resistant mutant.
出处 《药学学报》 CAS CSCD 北大核心 2010年第2期253-256,共4页 Acta Pharmaceutica Sinica
基金 美国Fogarty基金 国家高技术研究发展计划(863计划)资助项目(2004AA2Z3292)
关键词 艾滋病 HIV-1 抗HIV-1药物 中药复方 体外药效学 AIDS HIV-1 anti-HIV formulation Chinese herbs pharmacodynamics in vitro
  • 相关文献

参考文献9

  • 1Ito M, Nakashima H, Baba M, et al. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus[HIV(HTLV-III/LAV)] [J]. Antiviral Res, 1987,7: 127-137.
  • 2Chesebro B, Wehrly K. Development of a sensitive quantita- tive focal assay for human immunodeficiency virus infectivity [J]. J Virol, 1988, 62: 3779-3788.
  • 3Corrigan GE, AL-Khalili L, Malmsten A, et al. Differences in reverse transcriptase activity versus p24 antigen detection in cell culture, when comparing a homogeneous group of HIV type 1 subtype B viruses with a heterogeneous group of divergent strains [J]. AIDS Res Human Retroviruses 1998, 14: 347-352.
  • 4Piconi S, Trabanoni D, Fusi ML, et al. Effect of two different combinations of antiretrovirals (AZT+ddI and AZT+3TC) on cytokine production and aproptosis in asymptomatic HIV infection [J]. Antiviral Res, 2000, 40: 171-179.
  • 5Rank KB, Fan NS, Sharma SK. A rapid and quantitative assay for inhibition of 3' cleavage activity of HIV-1 integrase [J]. Antiviral Res, 1997, 36: 27-33.
  • 6Schols D, Este JA, Henson G, et al. Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4 [J]. Antiviral Res, 1997, 35: 147-156.
  • 7Roos JW, Maughan MF, Hildreth JEK. LuSIV cells: a reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication [J]. Virology, 2000, 273: 307-315.
  • 8Buckheit RW Jr, Russell JD, Xu ZQ. Anti-HIV-1 activity of calanolides used in combination with other mechanistically diverse inhibitors of HIV-1 replication [J]. Antiviral Chem Chemother, 2001, 11: 321-327.
  • 9Seki M, Sadakata Y, Yuasa S, et al. Isolation and characterization of human immunodefieiency virus type-1 mutants resistant to the non-nucleotide reverse transcriptase inhibitor MKC-442 [J]. Antiviral Chem Chemother, 1995, 6: 73-79.

同被引文献105

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部